Avant Technologies appoints Chris Winter as COO; receives quarterly RSA of 100,000 shares

AVAI BIO, INC.

Chris Winter appointed COO effective Nov 1, 2024; reports directly to the Board.
Compensation: quarterly RSA of 100,000 shares (67,000 prorated first quarter) at 85% of 30-day VWAP, floor $0.10.
Company pays tax gross-up bonus within 10 days of each share issuance.
Shares fully vested upon issuance; accelerated vesting on change of control (≥50% sale).
No relocation required; employee uses own laptop and phone.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.